NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $107,755 | -24.2% | 14,761 | -21.7% | 0.00% | – |
| Q2 2023 | $142,212 | +5.6% | 18,861 | -4.8% | 0.00% | – |
| Q1 2023 | $134,694 | -34.1% | 19,808 | -6.0% | 0.00% | – |
| Q4 2022 | $204,520 | -70.5% | 21,063 | -43.3% | 0.00% | -100.0% |
| Q3 2022 | $693,000 | -64.8% | 37,165 | -1.7% | 0.00% | -66.7% |
| Q2 2022 | $1,970,000 | -70.4% | 37,791 | -58.2% | 0.00% | -62.5% |
| Q1 2022 | $6,659,000 | -97.7% | 90,472 | -95.5% | 0.01% | -97.1% |
| Q4 2021 | $294,459,000 | +5165.7% | 2,010,246 | +7397.6% | 0.27% | +4433.3% |
| Q3 2021 | $5,592,000 | +25.7% | 26,812 | +27.8% | 0.01% | +20.0% |
| Q2 2021 | $4,447,000 | +432.6% | 20,987 | +352.4% | 0.01% | +400.0% |
| Q1 2021 | $835,000 | -38.2% | 4,639 | -61.2% | 0.00% | -50.0% |
| Q4 2020 | $1,352,000 | +511.8% | 11,964 | +497.3% | 0.00% | – |
| Q3 2020 | $221,000 | -57.8% | 2,003 | -68.2% | 0.00% | -100.0% |
| Q2 2020 | $524,000 | – | 6,290 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 132,500 | $2,414,000 | 0.77% |
| HAP Trading, LLC | 130,000 | $10,673,000 | 0.71% |
| Mendel Capital Management LLC | 23,835 | $434,000 | 0.51% |
| Faithward Advisors, LLC | 115,912 | $2,109,000 | 0.50% |
| Rock Springs Capital Management LP | 599,300 | $10,907,000 | 0.28% |
| SECTOR GAMMA AS | 56,735 | $1,033,000 | 0.27% |
| Quantitative Investment Management, LLC | 83,072 | $1,511,000 | 0.25% |
| LMR Partners LLP | 396,100 | $7,209,000 | 0.13% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1,333,706 | $24,273,000 | 0.13% |
| TSP Capital Management Group, LLC | 16,025 | $292,000 | 0.12% |